Effect of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethyluracil on mitochondrial functions in HepG2 cells

Antiviral Research

Volumn 43, Issue 3, 1999, Pages 201-207

  Cui, Lixin ^a   Faraj, Abdesslem ^a   Sommadossi, Jean Pierre ^a  

^a Division of Clinical Pharmacology   (United States)

Author keywords

D FEAU; Hepatitis B; Hepatotoxicity; Mitochondrial function

Indexed keywords

5 ETHYL 2' FLUOROURACIL ARABINOSIDE; LACTIC ACID; MITOCHONDRIAL DNA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN HEPG2; CELL STRUCTURE; CONTROLLED STUDY; DOSE RESPONSE; ELECTRON MICROSCOPY; IN VITRO STUDY; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL;

ARABINOFURANOSYLURACIL; CELL DIVISION; CELL LINE; HUMANS; MICROSCOPY, ELECTRON; MITOCHONDRIA;

EID: 0032834676     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00050-9     Document Type: Article

References (22)

1. Anderson S., Bankier A.T., Barrell B.G., de Brujin M.H.L., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J.H., Staden R., Young I.G. Sequence and organization of the human mitochondrial genome. Nature (London). 290:1981;457-465.
2. Chen C.H., Cheng Y.C. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J. Biol. Chem. 264:1989;11934-11937.
3. Chen C.H., Cheng Y.C. The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J. Biol. Chem. 267:1992;2856-2859.
4. Chou T.C., Kong X.B., Fanucchi M.P., Cheng Y.C., Takahashi K., Watanabe K.A., Fox J.J. Synthesis and biological effects of 2′-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil. Antimicrob. Agents Chemother. 31:1987;1355-1358.
5. Cui L., Yoon S., Schinazi R.F., Sommadossi J.-P. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells. J. Clin. Invest. 95:1995;555-563.
6. Cui L., Schinaze R.F., Gosselin G., Imbach J-L., Chu C.K., Rando R.F., Revankar G.R., Sommadossi J-P. Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells: implication for predicting drug hepatotoxicity. Biochem. Pharmacol. 52:1996;1577-1584.
7. Dalakas M.C., Illa I., Pezeshkpour G.H., Laukaitis J.P., Cohen B., Griffin J.L. Mitochondrial myopathy caused by long-term zidovudine therapy. New Engl. J. Med. 322:1990;1098-1105.
8. Darlington G.J., Kelly J.H., Buffone G.J. Growth and hepatospecific gene expression of huamn hepatoma cells in a defined medium. In Vitro Cell. Develop. Biol. 23(5):1987;349-354.
9. Dusheiko G.M. Fialuridine toxicity: new hopes and false downs. Intl. Antiviral News. 2:1994;22-23.
10. Fourel I., Hantz O., Watanabe K.A., Jacquet C., Chomel B., Fox J.J., Trepo C. Inhibitory effects of 2′-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks. Antimicrob. Agents Chemother. 34:1990;473-475.
11. Kong X.B., Scheck A.C., Price R.W., Vidal P.M., Fanucchi M.P., Watanabe K.A., Fox J.J., Chou T.C. Incorporation and metabolism of 2′-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells. Antiviral Res. 10:1988;153-166.
12. Kong X.B., Vidal P., Tong W.P., Chiang J., Gloff C.A., Chou T.C. Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2′-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats. Antimicrob. Agents Chemother. 36:1992;1472-1477.
13. Lewis W., Conzalez B., Chomyn A., Papoian T. Zidovudine induces molecular, biochemical and ultrastructural changes in rat skeletal muscle mitochondra. J. Clin. Invest. 89:1992;1354-1360.
14. Mansuri M.M., Chazzouli I., Chen M.S., Howell H.G., Brodfuehrer P.R., Benigni D.A., Martin J.C. 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent. J. Med. Chem. 30:1987;867-871.
15. Parker W.B., Cheng Y.C. Mitochondrial toxicity of antiviral nucleoside analogs. J. NIH Res. 6:1994;57-61.
16. Sassa S., Sugita O., Galbraith R.A., Kappas A. Drug metabolism by the human hepatoma cell, Hep-G2. Biochem. Biophys. Res. Commun. 143:1987;52-57.
17. Soike K.F., Chou T.C., Fox J.J., Watanabe K.A., Gloff C.A. Inhibition of simian varicella virus infection of monkeys by 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-ethyluracil (D-FEAU) and synergistic effects of combination with human recombinant interferon-beta. Antiviral Res. 13:1990;165-174.
18. Tennant B.C., Peek S.F., Tochkov I.A., Baldwin B.H., Hornbuckle W.E., Korba B.E., Cote P.J., Gerin J.L. The woodchuck in preclinical assessment of therapy for hepatitis B virus infection. Schinazi R.F., Sommadossi J.-P., Thomas H.C. Therapies for Viral Hepatitis. 1998;171-176 International Medical Press, London.
19. Touchette N. HBV-drug deaths prompt restudy of similar antivirals. J. NIH Res. 5:1993;33-35.
20. Trousdale M.D., Law J.L., Yarber F.A., Watanabe K.A., Fox J.J. Evaluation of 1-(2′-deoxy-2′-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil in a rabbit model of herpetic keratitis. Antiviral Res. 17:1992;157-167.
21. Tsai C.H., Doong S.L., Johns D.G., Driscoll J.S., Cheng Y.C. Effect of anti-HIV 2′-beta-fluoro-2′,3′-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production. Biochem. Pharmacol. 48:1994;1477-1481.
22. Wallace D.C. Disease of the mitochondrial DNA. Ann. Rev. Biochem. 61:1992;1175-1212.